Previous 10 | Next 10 |
Reports fourth quarter 2023 total revenue of $6.3 million , representing 45% growth compared to fourth quarter 2022 Reports 2023 revenue of $22.5 million , representing 31% growth compared t...
Eurofins Scientific S.E. (ERFSF) is expected to report for Q4 2023 Biodesix Inc. (BDSX) is expected to report $-0.1 for Q4 2023 Tapinator Inc (TAPM) is expected to report for quarter end 2023-12-31 Rapid Micro Biosystems Inc. (RPID) is expected to report $-0.31 for Q4 2023 Galapag...
LOWELL, Mass., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
2024-01-10 07:35:55 ET Rapid Micro Biosystems ( NASDAQ: RPID ) expects Q4 total revenue of $6.2M and $6.4M, representing growth of approximately 45% compared to the prior-year period. FY23 total revenue is anticipated in the range of $22.4M and $22.6M vs $22.41M cons...
The new Rapid Sterility application includes a novel, proprietary test kit that has been developed for use with the Company’s fully automated Growth Direct system and delivers time to organism detection in as little as 12 hours and final time-to-result in as little as one to three days ...
Full year 2023 total revenue expected to be between $22.4 million and $22.6 million, representing growth of over 30% compared to the prior year Fourth quarter 2023 total revenue expected to be between $6.2 million and $6.4 million, representing growth of approximately 45% compared t...
2024-01-04 10:00:42 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Omega Therapeutics Inc (NASDAQ: OMGA), Avenue Therapeutics Inc (NASDAQ: ATXI), Rapid Micro Biosystems Inc (NAS...
2024-01-04 07:42:11 ET DENVER, Colo., Jan. 4, 2024 ( www.247marketnews.com )- Rapid Micro Biosystems, Inc. (NASDAQ: RPID) stated, this morning, that Samsung Biologics selected the Growth Direct platform to automate its microbial quality control processes to deliver increased efficiency,...
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
News, Short Squeeze, Breakout and More Instantly...
Rapid Micro Biosystems Inc. Company Name:
RPID Stock Symbol:
NASDAQ Market:
Rapid Micro Biosystems Inc. Website:
LOWELL, Mass., July 17, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare...
Commercial National Financial Corp. (CNAF) is expected to report for Q1 2024 First National Bank Alaska (FBAK) is expected to report for Q1 2024 Cyxtera Technologies Inc. (CYXTQ) is expected to report for quarter end 2024-03-31 Brookfield Renewable Corporation Class A Subordinate (BEP...